Session » Posters: Quality, Health Services, and Education Research I

Date: Thursday, March 19, 2026

Time: 6:00PM-7:00PM

Meeting: 2026 Pediatric Rheumatology Symposium

6:00PM-7:00PM: Abstract Number: 054

Assessing Completion of Healthcare Transition: A Retrospective Review of Provider Acknowledgment Following Pediatric Rheumatology Transfer

6:00PM-7:00PM: Abstract Number: 062

Evaluating the Relationship Between an Electronic Transition Planning Tool and Transition Success in a Pediatric Rheumatology Clinic

6:00PM-7:00PM: Abstract Number: 068

Identification of Challenges in the Quality of Referrals to a Pediatric Rheumatology Center: A Retrospective Chart Review

6:00PM-7:00PM: Abstract Number: 060

Impact of Social Determinants of Health on Outcomes in Pediatric Uveitis

6:00PM-7:00PM: Abstract Number: 061

Impacts of Social Drivers of Health on Outcomes for Patients with Pediatric Systemic Lupus Erythematosus

6:00PM-7:00PM: Abstract Number: 063

Improving Pediatric Lupus Patient Education: Patient and Provider Needs Assessment

6:00PM-7:00PM: Abstract Number: 066

Incidence of Juvenile Idiopathic Arthritis in Chile: Estimates from a National Universal Access Program, 2010-2024

6:00PM-7:00PM: Abstract Number: 058

Increasing Reproductive Health Counseling and Screening in a Pediatric Rheumatology Clinic Using Quality Improvement Principles and Diverse Group of Stakeholders

6:00PM-7:00PM: Abstract Number: 056

Journey Maps of the Diagnostic Process: Insights from Caregivers of Patients with Juvenile Idiopathic Arthritis

6:00PM-7:00PM: Abstract Number: 057

Pediatric Learners’ Knowledge Retention and Diagnostic Confidence after High-Fidelity Pediatric Rheumatology Simulation

6:00PM-7:00PM: Abstract Number: 064

Recognizing Paradoxical Psoriasis in TNF-Inhibitor–Treated Pediatric Rheumatic Disease: A Saskatchewan Experience

6:00PM-7:00PM: Abstract Number: 055

Referrals Leading to Rheumatologic Diagnosis in a Pediatric Rheumatology Center: Influence of Referring Provider Practice and Training

6:00PM-7:00PM: Abstract Number: 065

Screening for Social Determinants of Health Identifies Differences Based on Insurance Types in a Single Pediatric Rheumatology Division

6:00PM-7:00PM: Abstract Number: 067

Standardizing Effective Education and Intervention for Chronic Non-Inflammatory Pain in Children with Juvenile Idiopathic Arthritis: A Quality Improvement Initiative

6:00PM-7:00PM: Abstract Number: 059

Use of Multimodal Teaching to Improve Resident Confidence in Evaluating Rheumatic Conditions

« View all sessions from this meeting

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].